(a)with the current vaccines and immunization schedule, 
(b)with a revised schedule, assuming the new ‘pentavalent’ vaccine is introduced as an all-liquid formulation, presented in single vials, and 
(c)with a revised schedule, assuming the new ‘pentavalent’ vaccine is introduced in a part-liquid, part-lyophilised formulation, using two separate vials